Shivom- Ico Review

chusnul (25)in #blockhain • 7 years ago

Now more and more new types of diseases that appear in various parts of the world that attack humans, new types of diseases that appear today is sometimes difficult to diagnose by the medical side. So this makes it difficult for doctors to give drugs which should be given to patients who contracted the new disease. Medical diagnosis or the determination of the type of disease based on signs and symptoms that exist in a person by using various means and tools, such as laboratories, photographs, and clinics is very important to determine which drugs should be given to patients.

And the problem of the current diagnosis has resulted in a very bad thing for patients, even lead to death. And according to current data there have been deaths of 10 million patients for 10 years due to misdiagnosis. And in Indonesia itself has often we hear of patient deaths due to misdiagnosis. Diagnostic errors are usually caused by factors such as a lack of doctor's knowledge of the illness suffered by the patient and the lack of time the doctor has to further analyze the patient's illness. Diagnose errors have caused a lot of casualties during this time, and now there are also many start ups who want to develop ways to help humanity from misdiagnosis, and one of them is Shivom, starts ups this will help health care industry with technology Blockchain. Follow the review from Shivom below to find out the benefits and goals it provides.

What Is SHIVOM?

Shivom connects two revolutionary technologies: genomics and blockchain to provide a safe and secure platform for storing genetic data and improving health and well-being. Shivom gives users access to a global precision drug platform that allows to share anonymous genetic information that can ultimately help cure complex diseases. Shivom creates a genomic ecosystem in blockchain.We will offer an open market for healthcare providers to add their applications and services, along with personalized genome and drug data analytics.

Shivom has designed a streamlined and user-friendly platform for all genomic & health data owners across the globe to share and collaborate with industry stakeholders everywhere.
The infographic above illustrates the easy steps for becoming part of the Shivom ecosystem.The workings of the Shivom platform and the benefits of using blockchain technology as the basis of the network is further described on the website and in the whitepaper.

The inclusion in clinical trials of genomes from a wide range of patients worldwide, would also vastly improve the development of precision medicines. Especially, when the genetic data of persons with disease-resistant mutations, unusual mutations & phenotypes is available for research purposes.
The global pooling of genomic sequencing data and the combining thereof with health records will further allow for improved collaboration between stakeholders in the biomedical industry, also for the leveraging of cutting-edge, analytical tools such as Big Data sampling.

Ultimately, the availability of a vast resource for research purposes, such as a shared, global, genomic data pool, will offer substantial benefit to the understanding of the causes of disease, the effective treatment thereof and contribute positively overall to successful patient outcomes.
And, as far as security goes, if data is spread across multiple, disparate, centralized databases, then it’s accessible through multiple points of entry. Which, as is evidenced by the regular media reports of global data breaches & malicious attacks by hackers, increases the vulnerability to unauthorized access.

Siloed and disparate, centralized data pools also do not allow for the effective adding & sharing of information by all stakeholders concerned, including the genomic data owners and all the other biomedical industry & commercial stakeholders.

While, the existence of a singular, secure, decentralized, global network would allow for easy access by all concerned, also the uploading of new genomic data from locations everywhere & anywhere in the world. It would further enable participants sufficient insight into their healthcare records and control over personal data.

Currently, patients are not adequately incentivized to partake in biomedical trials & studies, or to share their genomic information. They are also becoming increasingly aware that their data is being monetized by third parties and on a grand scale.
And, current generations are keen followers & advocates of the sharing economy. Not only are they demanding transparency, acknowledgment and participation, but also greater oversight concerning their personal data & wellbeing.

The solution – Shivom introduces genomics for everyone

Shivom’s Genomics Datahub & Healthcare Services Platform tackles the failures of today’s healthcare system head-on by offering the world’s first integrated, decentralized solution where everybody around the world can store their sequenced genome securely, own the rights to it and control who they share it with or sell it to.
Platform participants will include those who were previously excluded from healthcare services, such as rural or low-income areas. Through the inclusion of their genomes in the global data pool, such participants also will have access to biomedical counselors with whom they can work towards educated outcomes concerning their personalized healthcare.

Token info

Token OMX

Ethereum Platform

Type ERC20

Price in ICO1 ETH = 7000 OMX

Tokens for sale 990,000,000

Token OmiX

The OmiX Token is a key component that allows purchasing, trading, incentives, and other services. Tokens are fuels from the Shivom ecosystem, as well as parts of system governance.

Benefits of OmiX token:

Ability to obtain premium services in the Shivom ecosystem
Ability to obtain genome sequencing kits
Ability to sponsor a sequencing project
Ability to gain access to health / fitness applications from third-party providers
Ability to access genome database
Ability to pay donors for data / participation in research studies
The ability for service providers to use the platform

Management, Milestones & Roadmap

Shivom is under the capable leadership of Co-Founder & CEO Dr. Axel Schumacher, who is duly assisted by co-founders Gourish Singla and Sally Eaves, also 14 executives from around the world.
More information on the Team is available on the website. Also, the 8-member Shivom Innovation Council which supports, guides and advises the team.
Shivom’s exciting journey started years ago and already includes several milestones that have been achieved, with many more to come. The detailed Roadmap can be viewed online; also, the regular updates on Shivom’s News & Events.